Skip to main content

Advertisement

Log in

Behçet’s disease in Egypt: a multicenter nationwide study on 1526 adult patients and review of the literature

  • Original Article
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

A Correction to this article was published on 13 July 2019

This article has been updated

Abstract

Objectives

The present work was conducted to estimate the prevalence of adult Behçet’s disease (BD) in adult Egyptian and to study the clinical pattern and influence of age at-onset and sex on disease phenotype. Also, we investigated the spectrum of presentation and frequencies along the north-to-south gradient of the country.

Patients and method

The population-based, multicenter, cross-sectional study included 1526 adult BD patients from 26 specialized Egyptian rheumatology centers. Demographic, clinical, and therapeutic data are assessed for all patients.

Results

The mean age of patients was 35.7 ± 9.84 years, disease duration 6.58 ± 5.25 years, and age at onset 29.37 ± 8.6 years; 91 were juvenile-onset (JoBD). There were 1102 males and 424 females (M:F 2.6:1). Regarding co-morbidities, 19.92% were diabetic, and 26.05% were hypertensive. The mean body mass index was 27.57 ± 5.24 (43.1% overweight; 25.9% obese). The mean BD current activity form was 4.48 ± 4.28. Regarding the medications use, systemic steroid and colchicine were the most common drugs used (947 (90.2%) and 611 (82.7%), respectively). The overall estimated prevalence of BD in Egypt was 3.6/100,000 population being highest in the two main cities: Alexandria (15.27) and Cairo (8.72). Pathergy test was positive in 43.4%. 90.2% were receiving systemic steroids and 8.3%, biologics. Disease characteristics were comparable between JoBD and adult-onset BD cases. Central nervous system (CNS), deep venous thrombosis (DVT), and gastrointestinal (GIT) involvement were significantly higher in males (p = 0.01, p = 0.001, and p = 0.001 respectively) while joint affection (p = 0.001) and disease activity (p = 0.011) were increased in females.

Conclusions

This study provides current prevalence of BD in Egypt; 3.6/100,000 with no remarkable north-to-south gradient. The sex influences the disease phenotype with the CNS, DVT, and GIT involvement are higher in males, while the joint affection and disease activity were increased in females.

Key Points

The prevalence and phenotype of Behçet’s disease across Egypt is presented in a multicenter nationwide study.

The potential influence of the age at onset and sex on disease phenotype is highlightened.

A review of the literature worldwide is presented allowing comparisons with studies from other nations.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

Change history

  • 13 July 2019

    The author wishes to correct the record and clarify that in the original version of this article in the Discussion section under “Prevalence over the country governorates” inadvertently presented incorrect data cited in the reference [30].

References

  1. Gallizzi R, Pidone C, Cantarini L, Finetti M, Cattalini M, Filocamo G, Insalaco A, Rigante D, Consolini R, Maggio MC, Civino A, Martino S, Olivieri AN, Fabio G, Pastore S, Mauro A, Sutera D, Trimarchi G, Ruperto N, Gattorno M, Cimaz R (2017) A national cohort study on pediatric Behcet’s disease: cross-sectional data from an Italian registry. Pediatr Rheumatol Online J 15:84. https://doi.org/10.1186/s12969-017-0213-x

    Article  PubMed  PubMed Central  Google Scholar 

  2. Greco A, De Virgilio A, Ralli M et al (2018) Behcet’s disease: new insights into pathophysiology, clinical features and treatment options. Autoimmun Rev 17:567–575. https://doi.org/10.1016/j.autrev.2017.12.006

    Article  CAS  PubMed  Google Scholar 

  3. Gheita TA, Gheita HA, Kenawy SA (2016) The potential of genetically guided treatment in Behcet’s disease. Pharmacogenomics 17:1165–1174. https://doi.org/10.2217/pgs-2015-0004

    Article  CAS  PubMed  Google Scholar 

  4. Savey L, Resche-Rigon M, Wechsler B, Comarmond C, Piette J, Cacoub P, Saadoun D (2014) Ethnicity and association with disease manifestations and mortality in Behcet’s disease. Orphanet J Rare Dis 9:42. https://doi.org/10.1186/1750-1172-9-42

    Article  PubMed  PubMed Central  Google Scholar 

  5. Davatchi F, Chams-Davatchi C, Shams H, Shahram F, Nadji A, Akhlaghi M, Faezi T, Ghodsi Z, Sadeghi Abdollahi B, Ashofteh F, Mohtasham N, Kavosi H, Masoumi M (2017) Behcet’s disease: epidemiology, clinical manifestations, and diagnosis. Expert Rev Clin Immunol 13:57–65. https://doi.org/10.1080/1744666X.2016.1205486

    Article  CAS  PubMed  Google Scholar 

  6. Mohammad A, Mandl T, Sturfelt G, Segelmark M (2013) Incidence, prevalence and clinical characteristics of Behcet’s disease in southern Sweden. Rheumatology (Oxford) 52:304–310. https://doi.org/10.1093/rheumatology/kes249

    Article  Google Scholar 

  7. Davatchi F, Chams-Davatchi C, Ghodsi Z, Shahram F, Nadji A, Shams H, Akhlaghi M, Larimi R, Sadeghi-Abdolahi B (2011) Diagnostic value of pathergy test in Behcet’s disease according to the change of incidence over the time. Clin Rheumatol 30:1151–1155. https://doi.org/10.1007/s10067-011-1694-5

    Article  PubMed  Google Scholar 

  8. Ishido T, Horita N, Takeuchi M, Kawagoe T, Shibuya E, Yamane T, Hayashi T, Meguro A, Ishido M, Minegishi K, Yoshimi R, Kirino Y, Kato S, Arimoto J, Ishigatsubo Y, Takeno M, Kurosawa M, Kaneko T, Mizuki N (2017) Clinical manifestations of Behcet’s disease depending on sex and age: results from Japanese nationwide registration. Rheumatology (Oxford) 56:1918–1927. https://doi.org/10.1093/rheumatology/kex285

    Article  Google Scholar 

  9. Zeghidi H, Saadoun D, Bodaghi B (2014) [ocular manifestations in Behcet’s disease]. La. Rev Med Interne 35:97–102. https://doi.org/10.1016/j.revmed.2013.10.011

    Article  CAS  PubMed  Google Scholar 

  10. B’chir Hamzaoui S, Harmel A, Bouslama K et al (2006) Behcet’s disease in Tunisia. Clinical study of 519 cases. Rev Med Interne 27:742–750. https://doi.org/10.1016/j.revmed.2006.07.019

    Article  PubMed  Google Scholar 

  11. Davatchi F, Shahram F, Chams-Davatchi C et al (2012) Behcet’s disease: is there a gender influence on clinical manifestations? Int J Rheum Dis 15:306–314. https://doi.org/10.1111/j.1756-185X.2011.01696.x

    Article  PubMed  Google Scholar 

  12. (ITR-ICBD) IT for the R of the IC for BD, Davatchi F, Assaad-Khalil S, et al (2014) The International Criteria for Behçet’s Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria. J Eur Acad Dermatol Venereol 28:338–347

    Article  Google Scholar 

  13. Egypt 2018: Statistical abstract (2018) Central Agency for Public Mobilization and Statistics (CAPMAS). June. https://www.capmas.gov.eg/HomePage.aspx#

  14. Bhakta BB, Brennan P, James TE, Chamberlain MA, Noble BA, Silman AJ (1999) Behcet’s disease: evaluation of a new instrument to measure clinical activity. Rheumatology (Oxford) 38:728–733

    Article  CAS  Google Scholar 

  15. Kappen JH, van Dijk EHC, Baak-Dijkstra M, van Daele P, Lam-Tse WK, van Hagen P, van Laar J (2015) Behcet’s disease, hospital-based prevalence and manifestations in the Rotterdam area. Neth J Med 73:471–477

    CAS  PubMed  Google Scholar 

  16. Tunes RS, Anjos TC, Martins GB, Barreto ERM, Santiago MB (2009) Prevalence of Behcet’s syndrome in patients with recurrent aphthous ulcerations in Brazil. Rheumatol Int 29:875–878. https://doi.org/10.1007/s00296-008-0787-1

    Article  PubMed  Google Scholar 

  17. El Menyawi MM, Raslan HM, Edrees A (2009) Clinical features of Behcet’s disease in Egypt. Rheumatol Int 29:641–646. https://doi.org/10.1007/s00296-008-0741-2

    Article  PubMed  Google Scholar 

  18. Mahr A, Belarbi L, Wechsler B, Jeanneret D, Dhote R, Fain O, Lhote F, Ramanoelina J, Coste J, Guillevin L (2008) Population-based prevalence study of Behcet’s disease: differences by ethnic origin and low variation by age at immigration. Arthritis Rheum 58:3951–3959. https://doi.org/10.1002/art.24149

    Article  PubMed  Google Scholar 

  19. Assaad-Khalil SH, Kamel FA, Ismail EA (1997) Starting a regional registry for patients with Behçet’s disease in North West Nile Delta region in Egypt. In: Hamza M, editor. Behçet’s Disease. Tunis: Pub Adhoua 173–176

  20. Maldini C, Druce K, Basu N, LaValley MP, Mahr A (2018) Exploring the variability in Behcet’s disease prevalence: a meta-analytical approach. Rheumatology (Oxford) 57:185–195. https://doi.org/10.1093/rheumatology/kew486

    Article  Google Scholar 

  21. Colgecen E, Ozyurt K, Ferahbas A et al (2015) The prevalence of Behcet’s disease in a city in Central Anatolia in Turkey. Int J Dermatol 54:286–289. https://doi.org/10.1111/ijd.12173

    Article  PubMed  Google Scholar 

  22. Benamour S, Naji T, Alaoui F-Z, el Kabli H, el Aidouni S (2006) Neurological involvement in Behcet’s disease. 154 cases from a cohort of 925 patients and review of the literature. Rev Neurol (Paris) 162:1084–1090

    Article  CAS  Google Scholar 

  23. Dia D, Dieng MT, Sy Ndiaye T, Fall S, Ndongo S, Diallo M, Moreira Diop T, Labou A, Ndiaye B (2003) Behcet’s disease in Dakar (Senegal): epidemiological and clinical features. Dakar Med 48:64–67

    CAS  PubMed  Google Scholar 

  24. Yurdakul S, Gunaydin I, Tuzun Y et al (1988) The prevalence of Behcet’s syndrome in a rural area in northern Turkey. J Rheumatol 15:820–822

    CAS  PubMed  Google Scholar 

  25. Cakir N, Dervis E, Benian O, Pamuk ON, Sonmezates N, Rahimoglu R, Tuna S, Cetin T, Sarikaya Y (2004) Prevalence of Behcet’s disease in rural western Turkey: a preliminary report. Clin Exp Rheumatol 22:S53–S55

    CAS  PubMed  Google Scholar 

  26. Suzuki T, Horita N, Takeuchi M, Ishido T, Mizuki Y, Mizuki R, Kawagoe T, Shibuya E, Yuta K, Yamane T, Hayashi T, Meguro A, Ishido M, Minegishi K, Yoshimi R, Kirino Y, Kato S, Arimoto J, Fukumoto T, Ishigatsubo Y, Kurosawa M, Takeno M, Kaneko T, Mizuki N (2018) Clinical features of early-stage possible Behcet’s disease patients with a variant-type major organ involvement in Japan. Mod Rheumatol:1–7. https://doi.org/10.1080/14397595.2018.1494501

  27. Lin Y-H, Tai T-Y, Pu C-Y, Hwang DK, Chung YM, Chou YJ (2018) Epidemiology of Behcet’s disease in Taiwan: a population-based study. Ophthalmic Epidemiol 25:323–329. https://doi.org/10.1080/09286586.2018.1469157

    Article  PubMed  Google Scholar 

  28. Kim JN, Kwak SG, Choe J-Y, Kim S-K (2017) The prevalence of Behcet’s disease in Korea: data from Health Insurance Review and Assessment Service from 2011 to 2015. Clin Exp Rheumatol 35(Suppl 1):38–42

    PubMed  Google Scholar 

  29. Zeidan MJ, Saadoun D, Garrido M, Klatzmann D, Six A, Cacoub P (2016) Behcet’s disease physiopathology: a contemporary review. Auto Immun Highlights 7:4. https://doi.org/10.1007/s13317-016-0074-1

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Madanat WY, Alawneh KM, Smadi MM et al (2017) The prevalence of Behcet’s disease in the north of Jordan: a hospital-based epidemiological survey. Clin Exp Rheumatol 35(Suppl 1):51–54

    PubMed  Google Scholar 

  31. Lennikov A, Alekberova Z, Goloeva R, Kitaichi N, Denisov L, Namba K, Takeno M, Ishigatsubo Y, Mizuki N, Nasonov E, Ishida S, Ohno S (2015) Single center study on ethnic and clinical features of Behcet’s disease in Moscow, Russia. Clin Rheumatol 34:321–327. https://doi.org/10.1007/s10067-013-2442-9

    Article  PubMed  Google Scholar 

  32. Davatchi F, Shahram F, Chams-Davatchi C et al (2010) Behcet’s disease in Iran: analysis of 6500 cases. Int J Rheum Dis 13:367–373. https://doi.org/10.1111/j.1756-185X.2010.01549.x

    Article  PubMed  Google Scholar 

  33. Olivieri I, Leccese P, Padula A, Nigro A, Palazzi C, Gilio M, D'Angelo S (2013) High prevalence of Behçet’s disease in southern Italy. Clin Exp Rheumatol 31:28–31

    PubMed  Google Scholar 

  34. Bonitsis NG, Luong Nguyen LB, LaValley MP et al (2015) Gender-specific differences in Adamantiades-Behcet’s disease manifestations: an analysis of the German registry and meta-analysis of data from the literature. Rheumatology (Oxford) 54:121–133. https://doi.org/10.1093/rheumatology/keu247

    Article  CAS  Google Scholar 

  35. Rodríguez-Carballeira M, Alba MA, Solans-Laqué R, Castillo MJ, Ríos-Fernández R, Larrañaga JR, Martínez-Berriotxoa A, Espinosa G, REGEB investigators (2014) Registry of the Spanish network of Behçet’s disease: a descriptive analysis of 496 patients. Clin Exp Rheumatol 32:S33–S39

    PubMed  Google Scholar 

  36. Gheita TA, Eesa NN (2018) Rheumatology in Egypt: back to the future. Rheumatol Int 39:1–12. https://doi.org/10.1007/s00296-018-4192-0

    Article  CAS  PubMed  Google Scholar 

  37. Balta I, Akbay G, Kalkan G, Eksioglu M (2014) Demographic and clinical features of 521 Turkish patients with Behcet’s disease. Int J Dermatol 53:564–569. https://doi.org/10.1111/j.1365-4632.2012.05756.x

    Article  PubMed  Google Scholar 

  38. Kitaichi N, Miyazaki A, Stanford MR, Iwata D, Chams H, Ohno S (2009) Low prevalence of juvenile-onset Behcet’s disease with uveitis in east/south Asian people. Br J Ophthalmol 93:1428–1430. https://doi.org/10.1136/bjo.2008.154476

    Article  CAS  PubMed  Google Scholar 

  39. Sharquie KE, Al-Rawi Z, Hatem A, Al-Araji A (2002) The influence of age of onset and patient’s sex on the prevalence of clinical manifestations of Behcet’s disease in Iraqi patients. Ann Saudi Med 22:239–241

    Article  PubMed  Google Scholar 

  40. Zhang Z, He F, Shi Y (2013) Behcet’s disease seen in China: analysis of 334 cases. Rheumatol Int 33:645–648. https://doi.org/10.1007/s00296-012-2384-6

    Article  CAS  PubMed  Google Scholar 

  41. Sachetto Z, Mahayri N, Ferraz RH, Costallat LTL, Bertolo MB (2012) Behcet’s disease in Brazilian patients: demographic and clinical features. Rheumatol Int 32:2063–2067. https://doi.org/10.1007/s00296-011-1921-z

    Article  PubMed  Google Scholar 

  42. Petty RE, Cabral DA (2016) Chapter 32 - Vasculitis and Its Classification. In: Petty RE, Laxer RM, Lindsley CB (eds) Wedderburn LRBT-T of PR, 7th edn. W.B. Saunders, Philadelphia, pp 448–451.e1

    Google Scholar 

  43. Davatchi F (2014) Behcet’s disease. Int J Rheum Dis 17:355–357. https://doi.org/10.1111/1756-185X.12378

    Article  PubMed  Google Scholar 

  44. El-Najjar AR, Abou El-Soud AM, Amar HA, Diab MAS (2015) Clinical characteristics and disease activity of Behçet’s disease patients in Zagazig, Egypt. Egypt Rheumatol 37:191–196. https://doi.org/10.1016/j.ejr.2014.11.009

    Article  Google Scholar 

  45. Lee YB, Lee SY, Choi JY, Lee JH, Chae HS, Kim JW, Han KD, Park YG, Yu DS (2018) Incidence, prevalence, and mortality of Adamantiades-Behcet’s disease in Korea: a nationwide, population-based study (2006-2015). J Eur Acad Dermatol Venereol 32:999–1003. https://doi.org/10.1111/jdv.14601

    Article  CAS  PubMed  Google Scholar 

  46. Ryu HJ, Seo MR, Choi HJ, Baek HJ (2018) Clinical phenotypes of Korean patients with Behcet disease according to gender, age at onset, and HLA-B51. Korean J Intern Med 33:1025–1031. https://doi.org/10.3904/kjim.2016.202

    Article  PubMed  CAS  Google Scholar 

  47. Zayed H, Effat D, Nawito Z, Abdou AA, el Din MN, el-Refaei S, Amin M, Mohamed Y, Amin A, Wafie A, Abu el-Einin K (2011) Silent central nervous system involvement in Egyptian Behcet’s disease patients: clinical, psychiatric, and neuroimaging evaluation. Clin Rheumatol 30:1173–1180. https://doi.org/10.1007/s10067-011-1725-2

    Article  PubMed  Google Scholar 

  48. Kidd D (2006) The prevalence of headache in Behcet’s syndrome. Rheumatology (Oxford) 45:621–623. https://doi.org/10.1093/rheumatology/kei255

    Article  CAS  Google Scholar 

  49. Sarica-Kucukoglu R, Akdag-Kose A, KayabalI M et al (2006) Vascular involvement in Behcet’s disease: a retrospective analysis of 2319 cases. Int J Dermatol 45:919–921. https://doi.org/10.1111/j.1365-4632.2006.02832.x

    Article  PubMed  Google Scholar 

  50. Yi SW, Cheon JH, Kim JH, Lee SK, Kim TI, Lee YC, Kim WH (2009) The prevalence and clinical characteristics of esophageal involvement in patients with Behcet’s disease: a single center experience in Korea. J Korean Med Sci 24:52–56. https://doi.org/10.3346/jkms.2009.24.1.52

    Article  PubMed  PubMed Central  Google Scholar 

  51. Kocak E, Akbal E, Beyazit Y et al (2017) Celiac disease prevalence in a large series of patients with Behcet’s disease. Int J Rheum Dis 21:2146–2150. https://doi.org/10.1111/1756-185X.12990

    Article  PubMed  Google Scholar 

  52. Lankarani KB, Ravanbod MR, Aflaki E, Nazarinia MA, Rajaee A (2014) High prevalence of Helicobacter pylori infection in Behcet’s disease. BMC Gastroenterol 14:58. https://doi.org/10.1186/1471-230X-14-58

    Article  PubMed  PubMed Central  Google Scholar 

  53. Yazici H, Tuzun Y, Pazarli H, Yurdakul S, Ozyazgan Y, Ozdogan H, Serdaroglu S, Ersanli M, Ulku BY, Muftuoglu AU (1984) Influence of age of onset and patient’s sex on the prevalence and severity of manifestations of Behcet’s syndrome. Ann Rheum Dis 43:783–789

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  54. Gyldenlove M, Tvede N, Larsen JL et al (2014) Low prevalence of positive skin pathergy testing in Danish patients with Behcet’s disease. J Eur Acad Dermatol Venereol 28:259–260. https://doi.org/10.1111/jdv.12189

    Article  CAS  PubMed  Google Scholar 

  55. Koca SS, Kara M, Ozgen M, Dayanan R, Demir CF, Aksoy K, Ilhan N, Donder E, Isik A (2017) Low prevalence of obesity in Behcet’s disease is associated with high obestatin level. Eur J Rheumatol 4:113–117. https://doi.org/10.5152/eurjrheum.2017.160095

    Article  PubMed  PubMed Central  Google Scholar 

  56. Afshin A, Forouzanfar MH, Reitsma MB et al (2017) Health effects of overweight and obesity in 195 countries over 25 years. N Engl J Med 377:13–27. https://doi.org/10.1056/NEJMoa1614362

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Consortia

Corresponding author

Correspondence to Tamer A. Gheita.

Ethics declarations

Disclosures

None.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gheita, T.A., El-Latif, E.A., El-Gazzar, I.I. et al. Behçet’s disease in Egypt: a multicenter nationwide study on 1526 adult patients and review of the literature. Clin Rheumatol 38, 2565–2575 (2019). https://doi.org/10.1007/s10067-019-04570-w

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-019-04570-w

Keywords

Navigation